Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
35 hedge funds and large institutions have $96.3M invested in Global Cord Blood Corporation in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
3% less capital invested
Capital invested by funds: $99.1M → $96.3M (-$2.76M)
20% less funds holding
Funds holding: 44 → 35 (-9)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$470K |
| 2 |
Squarepoint
New York
|
+$147K |
| 3 |
AC
Athos Capital
Hong Kong
|
+$119K |
| 4 |
BlackRock
New York
|
+$81K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
-$3.71M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$932K |
| 3 |
Goldman Sachs
New York
|
-$337K |
| 4 |
Millennium Management
New York
|
-$303K |
| 5 |
LAM
Lingohr Asset Management
Duesseldorf,
Germany
|
-$301K |
CO Hedge Fund Activity: Q4 2019 in Review
35 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2019, worth a combined $96.3M — down 2.8% from $99.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CO and 2 opened new positions — a net loss of 9 holders — while 12 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $470K. The largest seller was Jayhawk Capital Management, cutting an estimated $3.71M.
- 35 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2019, down from 44 in Q3 2019.
- Funds reported $96.3M of Global Cord Blood Corporation stock for Q4 2019, down 2.8% quarter-over-quarter.
- 2 funds opened new Global Cord Blood Corporation positions in Q4 2019 and 11 closed out, a net change of -9 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $470K added.
- The largest Global Cord Blood Corporation seller in Q4 2019 was Jayhawk Capital Management, an estimated $3.71M sold.
Based on aggregated 13F filings for Q4 2019.